BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11208840)

  • 1. Solid cancers after bone marrow transplantation.
    Bhatia S; Louie AD; Bhatia R; O'Donnell MR; Fung H; Kashyap A; Krishnan A; Molina A; Nademanee A; Niland JC; Parker PA; Snyder DS; Spielberger R; Stein A; Forman SJ
    J Clin Oncol; 2001 Jan; 19(2):464-71. PubMed ID: 11208840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
    Socié G; Curtis RE; Deeg HJ; Sobocinski KA; Filipovich AH; Travis LB; Sullivan KM; Rowlings PA; Kingma DW; Banks PM; Travis WD; Witherspoon RP; Sanders J; Jaffe ES; Horowitz MM
    J Clin Oncol; 2000 Jan; 18(2):348-57. PubMed ID: 10637249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid cancers after bone marrow transplantation.
    Curtis RE; Rowlings PA; Deeg HJ; Shriner DA; Socíe G; Travis LB; Horowitz MM; Witherspoon RP; Hoover RN; Sobocinski KA; Fraumeni JF; Boice JD
    N Engl J Med; 1997 Mar; 336(13):897-904. PubMed ID: 9070469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation.
    Hasegawa W; Pond GR; Rifkind JT; Messner HA; Lau A; Daly AS; Kiss TL; Kotchetkova N; Galal A; Lipton JH
    Bone Marrow Transplant; 2005 Jan; 35(1):51-5. PubMed ID: 15516939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary malignancies after bone marrow transplantation in adults.
    Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
    J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease.
    Atsuta Y; Suzuki R; Yamashita T; Fukuda T; Miyamura K; Taniguchi S; Iida H; Uchida T; Ikegame K; Takahashi S; Kato K; Kawa K; Nagamura-Inoue T; Morishima Y; Sakamaki H; Kodera Y;
    Ann Oncol; 2014 Feb; 25(2):435-41. PubMed ID: 24399081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
    Baker KS; DeFor TE; Burns LJ; Ramsay NK; Neglia JP; Robison LL
    J Clin Oncol; 2003 Apr; 21(7):1352-8. PubMed ID: 12663726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation.
    Lawton CA; Cohen EP; Murray KJ; Derus SW; Casper JT; Drobyski WR; Horowitz MM; Moulder JE
    Bone Marrow Transplant; 1997 Dec; 20(12):1069-74. PubMed ID: 9466280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood.
    Cohen A; Rovelli A; van Lint MT; Merlo F; Gaiero A; Mulas R; Balduzzi A; Corti P; Uderzo C; Bacigalupo A
    Bone Marrow Transplant; 2001 Dec; 28(12):1125-8. PubMed ID: 11803353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A; Rovelli A; Merlo DF; van Lint MT; Lanino E; Bresters D; Ceppi M; Bocchini V; Tichelli A; Socié G
    J Clin Oncol; 2007 Jun; 25(17):2449-54. PubMed ID: 17557958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
    McDonald AM; Chen Y; Wu J; Hageman L; Francisco L; Kung M; Wong FL; Ness E; Landier W; Battles K; Salzman D; Weisdorf DJ; Forman SJ; Arora M; Armenian SH; Bhatia S
    J Clin Oncol; 2020 Sep; 38(25):2872-2882. PubMed ID: 32673169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
    Rowlings PA; Curtis RE; Passweg JR; Deeg HJ; Socié G; Travis LB; Kingma DW; Jaffe ES; Sobocinski KA; Horowitz MM
    J Clin Oncol; 1999 Oct; 17(10):3122-7. PubMed ID: 10506608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K; Yokozawa T; Atsuta Y; Kohno A; Maruyama F; Yano K; Taji H; Kitaori K; Goto S; Iida H; Morishima Y; Kodera Y; Naoe T; Morishita Y
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
    McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
    JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran.
    Saddadi F; Najafi I; Hakemi MS; Falaknazi K; Attari F; Bahar B
    Iran J Kidney Dis; 2010 Jan; 4(1):20-6. PubMed ID: 20081300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group.
    Bhatia S; Yasui Y; Robison LL; Birch JM; Bogue MK; Diller L; DeLaat C; Fossati-Bellani F; Morgan E; Oberlin O; Reaman G; Ruymann FB; Tersak J; Meadows AT;
    J Clin Oncol; 2003 Dec; 21(23):4386-94. PubMed ID: 14645429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.